Sponsors

Beckman Coulter is a leading provider of instrument systems and complementary products that simplify and automate processes in life science and clinical laboratories. The company's products are used throughout the world in all phases of the battle against disease, from pioneering medical research and drug discovery to diagnostic testing that aids in patient treatment. For the clinical diagnostics marketplace, Beckman Coulter offers a number of innovative laboratory automation systems, clinical chemistry systems, hematology analysis systems, immunochemistry systems, centrifuges, flow cytometry systems, rapid-test kits, reagents and quality control chemistries.

Ortho-Clinical Diagnostics, Inc., part of the Johnson & Johnson Family of Companies, delivers the high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care.

Roche Diagnostics supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals, and laboratories worldwide. For more than 100 years, the company has demonstrated its commitment to product quality, scientific innovation, and conscientious service. Roche recognizes its particular responsibility to the health care community, to its employees and shareholders, and above all, to the patients who depend on accurate diagnosis for their well being. Roche Diagnostics is part of the Roche Group, one of the world's leading research-oriented healthcare organizations in the fields of pharmaceuticals, diagnostics, and vitamins.

Siemens Healthcare Diagnostics offers a broad portfolio of performance-driven diagnostic solutions that provide more effective ways to assist in the diagnosis, management and monitoring of disease. Our products and services bring together the right balance of science, technology and practicality across the healthcare continuum to empower medical professionals with the vital information they need to deliver better, more personalized care to patients around the globe. Visit us at www.siemens.com/diagnostics.

Abbott Diagnostics is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, blood banks, physician offices and clinics. With more than 69,000 institutional customers in more than 100 countries, Abbott diagnostic products offer customers automation, convenience, cost effectiveness and flexibility. The history of Abbott Diagnostics is filled with examples of first-of-a-kind products and significant technological advancements. Abbott Diagnostics is a part of Abbott Laboratories, a broad-based health care company with products that span the continuum of care—from prevention and diagnosis to treatment and cure.

Spectra Laboratories, Inc. is the leading provider of renal-specific laboratory services in the dialysis industry. Spectra's state-of-the-art analytical equipment, automated specimen processing and reporting applications provide more than 41 million test results annually, reaching over 147,000 patients in 2,100 free-standing and hospital-based dialysis facilities across the United States. Spectra also supplies central laboratory services to a variety of clinical trials through its Spectra Clinical Research division.

Spectra Laboratories, a wholly owned subsidiary of Fresenius Medical Care Holdings, the world's largest vertically integrated dialysis service provider, has more than 800 employees in its Fremont, Calif. and Rockleigh, N.J. facilities.

Phadia developed the first commercial IgE blood test more than 40 years ago, and is the world leader in allergy diagnostics. ImmunoCAP^® technology is regarded as the reference standard for specific IgE testing and was the testing method of choice in over 2,000 scientific publications. Phadia recently introduced the EliA^® line of autoimmune tests to the US, and now offers a full menu of assays to aid in the diagnosis of celiac disease, rheumatoid arthritis, connective tissue disease, and many other autoimmune disorders. Phadia’s ongoing commitment to innovation continues to advance immunoassay technology, with the development of ImmunoCAP Molecular Allergy as well as new specific protein assays for autoimmune diseases.

Fujirebio Diagnostics, Inc. (FDI), formerly Centocor Diagnostics, is a premier diagnostic company and the industry leader worldwide in tumor marker assays. Core products include the gold standard CA125II™, CA19-9™, CA15-3©, CA72-4©, and CYFRA21-1™ assays. FDI's primary focus is in the development, manufacture, and commercialization of in vitro diagnostic oncology products.

Hycor Biomedical Inc. is a manufacturer and supplier of products that include the fully automated EIA HY-TEC™ 480 and HY-TEC™ 288 systems for allergy and autoimmune testing and the KOVA® Standardized System for Urinalysis. Hycor offers a broad menu of over 950 allergens and, in the United States, offers 26 510(k)-cleared ELISA-based AUTOSTAT™ II autoimmune assays for automated and manual testing. Hycor Biomedical Inc. meets international quality manufacturing standards including ISO 9001/EN 46001 and is dedicated to providing the highest levels of customer support and services to distributors and end-users worldwide.

ITC Nexus Dx is the leader in the development and manufacture of POC coagulation diagnostic testing products, as well as in the development and manufacture of precision, automated skin incision technologies. ITC's product portfolio includes: Hemochron® Response and Signature product lines (used in coagulation testing in the operating room, cardiac catheterization lab, and critical care areas of the hospital); ProTime® products (used for Prothrombin Time (PT) testing in physician office labs and in patient self-testing at home); and Tenderfoot® , Tenderlett® and Surgicutt® automated incision technologies (used in obtaining blood samples via skin incision and fingersticks).

Sysmex Corporation is a leading international manufacturer of diagnostic and information systems, developing clinical laboratory analyzers, reagents and software for hematology, hemostasis, and urinalysis. Sysmex products are distributed in more than 150 countries, ranked #2 in hemostasis and hematology placements and #1 in automated urine formed element analysis globally. To respond to the needs of customers throughout the world, Sysmex has a global corporate network of marketing, production, research and development in 12 countries, including Sysmex Corporation of America. Sysmex offers customized solutions that enhance clinical information and increase productivity by integrating technological innovation, automation platforms and information solutions worldwide.

Randox is a global diagnostic solutions company headquartered in the UK with distribution in a further 130 countries. With 30 years of experience in this field, Randox has a strong research and development ethos ensuring innovative, high quality solutions are produced. The new Evidence Evolution is the world’s first random access biochip testing platform. Utilising Biochip Array Technology as developed by Randox, it offers revolutionary multiplexing of many routine and novel biomarkers. Arrays cover disease states such as cardiovascular disease, cancer, infectious diseases, respiratory as well as drugs of abuse and drug residue screening. The Randox portfolio also includes clinical chemistry analysers and reagents, including H-FABP and TxB Cardio Assays which are set to revolutionise cardiovascular healthcare. Quality Control, EQA programmes, IQC software and a full life science range complete the offering. All Randox products offer efficiency, flexibility, quality and cost-effectiveness to meet the needs of all laboratory types.

For over 35 years, Sebia has been 100% focused on the science of electrophoresis. Sebia’s mission is to provide the solution for every clinical electrophoresis laboratory by increasing productivity through improved technology and by providing both traditional and innovative assays producing only the highest quality results. From our quality manual assays to the semi-automated HYDRASYS® agarose gel system to – now – the completely walk-away CAPILLARYS™ capillary electrophoresis system, Sebia continues to revolutionize the world of electrophoresis testing.

PAML is a medical reference laboratory serving physicians, hospitals, members of the community, employers, and other allied health professionals. Currently, PAML is ranked among the top clinical reference laboratories in the nation and is considered an industry leader in joint venture partnerships with community-based hospitals.

PROFESSIONAL CO-OP, an original model launched in 2001 to support the alternative and complementary health care community, provides appropriately licensed clinicians with access to major lab services for a fraction of the typical costs. There are no fees and no minimums. Our staff is knowledgeable, professional, and experienced in handling the issues and problems commonly seen in lab testing. PCS allows the clinician to focus on what’s most important, patient care, at substantial savings.

Antek HealthWare, a CompuGroup Medical company, developer of LabDAQ Laboratory Information System, is the trusted source of laboratory information used by thousands of physicians and laboratory professionals every day. LabDAQ has become the nation's leading LIS, used in over 2,500 sites nationwide. LabDAQ can be found in virtually every clinical laboratory environment and can easily meet the needs of labs in hospitals, clinics, physician office labs and reference laboratories.

Sponsors

Premier

Sponsor